Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. - Wikidata - wikimedia - TriplyDB

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

http://www.wikidata.org/entity/Q54115668

about

Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies Role of endothelin in cardiovascular disease Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease Endothelin receptor antagonists and cerebral vasospasm: an update.Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.Endothelin in heart failure.Recent advances in the management of chronic heart failure.New and emerging pharmacologic strategies in the management of chronic heart failure.The role of endothelin receptor antagonists in the treatment of chronic heart failure.Novel therapeutics for the treatment of paediatric pulmonary arterial hypertension.The therapeutic potential of endothelin receptor antagonists in cardiovascular disease.Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.Endothelin antagonists and heart failure.Endothelin receptor antagonists in cardiology clinical trials.Present and future pharmacotherapy for heart failure.Bosentan: a dual endothelin receptor antagonist.Heart failure in 10 years time: focus on pharmacological treatment.The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system.Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone The rational use of diuretics in heart failure.Treatment of congestive heart failure a neuroendocrine disorder.Role of endothelins in congestive heart failure.Acute endothelin A receptor antagonism improves pulmonary and systemic haemodynamics in patients with pulmonary arterial hypertension that is primary or autoimmune and related to congenital heart disease Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure.Tezosentan in the treatment of acute heart failure.Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo Is too much neurohormonal blockade harmful?Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management.Effect of bosentan on pulmonary hypertension secondary to systolic heart failure.Endothelins: pathophysiology and treatment implications in chronic heart failure.Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers.Future pharmacologic agents for treatment of heart failure in children.The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth.Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists?Cardiac Fibrosis: The Fibroblast Awakens Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization.Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy.Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?

P2860

Q26746907-9A049C0D-D94D-46C7-9850-706D32B51A42 Q28216230-18EF447A-9D57-498A-A67C-C017605B8660 Q28263963-54EBA279-7BC1-4CA8-B447-FE0A8EE6420A Q30310232-106ED932-1711-4DA1-8556-DA4AD9235AAC Q31355796-A0A4F6E4-6D77-4400-B893-67A78F3DD185 Q33653672-7AD04BDE-493E-4FB1-A1D8-623E37712B2C Q34028140-60321F22-6C10-4B24-856E-B29FF37B4176 Q34031741-DBA015CC-7D8B-4658-8B50-DCD1B90C6937 Q34075359-CB3846EF-1DC0-405C-A5D3-76F0DF98D72F Q34221061-5F6A67EF-B45C-4E78-BE34-7120368687A4 Q34232006-64CFB8AD-F36E-4EA7-8BC2-4867244DCEDB Q34317655-D588AFDC-6F9B-4A89-9E73-3CE68E980F6C Q34448373-47EF1CA4-8C97-4D28-967E-A66B0055E3B4 Q34492848-0F69B876-5BE3-48D6-A69C-77A7019EDB9E Q34544685-86E70592-29D4-4E6C-9CCC-FD9875A78C88 Q34706912-203B182B-2ED0-47D5-A62F-8BBA7324F4C0 Q34707006-AA9B72B1-365F-4417-907C-FB60EB3FE649 Q34817094-D57AA7A6-7C75-4423-B4AE-7F252CA0B7EF Q35001002-BF0580AB-05A7-4421-98EE-4DD845B8A4CE Q35044124-C6DC08C0-77A6-4DCB-B8C9-5672217DB4B2 Q35105848-EA893CF3-F07A-47BA-B798-4CA2685A92EF Q35110636-F5A16AE1-8CA2-45DF-AC8B-78B59A86B88D Q35168419-04F6A006-6926-43F1-9A47-6CC07A04A3D5 Q35581586-103FFCEA-02B5-4119-B9A2-669673EB3906 Q35584359-CDBCB5D0-5FDC-48F5-828E-419CE49AEFF1 Q35590982-26857361-6B9E-4AD3-B035-8E2899C57B0C Q35631333-CEE4AA2A-3B8F-4BA3-BA4F-4D8FE5FA7C1C Q35653851-548AE71E-8C82-49E2-A076-C6EB69FC400E Q35742253-0448F7BD-632C-4B49-A91E-3BC61F4D6276 Q36013674-709B67EC-53A0-4DAE-A0F1-34FA04AE4C7D Q36302304-96B714CD-7CC6-4DE9-B979-248025617816 Q36332869-7450B7DB-42A0-4702-AC44-F68E30DD3007 Q36543145-A4026969-F0FE-48B1-8891-078505171D72 Q36577692-371474AC-6939-47E7-B6B8-40962F1513AA Q36610320-B51E6BF9-4EED-47E2-B1AE-6802691A9AA9 Q36674362-837E3B92-1B7B-4C9D-A3ED-881501BEF956 Q36708340-28D17FC0-0207-43E7-AA45-0534D090BE26 Q36717615-267D95C0-885B-4EE1-A42B-7F3569AF420A Q36814875-794BDF0B-6C1A-4690-9AEE-F3651A13B5A5 Q36836706-99DEFF6A-633B-4F23-A813-514C5679301A

P2860

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

http://www.wikidata.org/entity/Q54115668

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Short-term oral endothelin-rec ...... severe chronic heart failure.

@en

Short-term oral endothelin-rec ...... severe chronic heart failure.

@nl

type

label

Short-term oral endothelin-rec ...... severe chronic heart failure.

@en

Short-term oral endothelin-rec ...... severe chronic heart failure.

@nl

prefLabel

Short-term oral endothelin-rec ...... severe chronic heart failure.

@en

Short-term oral endothelin-rec ...... severe chronic heart failure.

@nl

P1433

Q54115668-F998F277-21AF-46DA-9B80-8DF6D1EF5EC1

P1476

Q54115668-CF464DCF-38B5-4FE3-B2E1-DBD5D1376A16

P2093

Q54115668-0E4C80B7-28AC-488A-A03D-98924BDDF4ED

Q54115668-46BD0DF9-D9FE-4C67-94AE-9FABFE0ED5D6

Q54115668-4ECC5C76-20EF-45D1-ADFF-0D4CB7072EA0

Q54115668-5E8E43BA-1FE8-49D1-AD51-99CD10225DDD

Q54115668-741A3BDC-F2BD-4D71-83BF-DCA6DA626B7B

Q54115668-8095466C-8073-4214-93CC-935A89D1BDEE

Q54115668-A83FC1AB-ACA8-4DA1-B318-0D668159031C

Q54115668-C294D703-6FA1-4A20-8E1C-54B70062899D

Q54115668-E8EE3ECE-CB91-4FBE-820A-8218825B9647

P304

Q54115668-2A30F69F-414E-4B63-BF06-960D89E9C4F6

P31

Q54115668-ECD9F515-5E54-4CCA-8B3C-348AFAB7A9EC

P356

Q54115668-0EE98D37-546F-455D-8BFD-D008CBD7C91D

P407

Q54115668-615B700C-EC82-43DA-A373-5FE658FAAB3E

P433

Q54115668-8D135FDE-57CE-4C0F-A30F-515088C1B404

P478

Q54115668-F8046928-E098-4448-99C8-EFD5EEEAD5F4

P577

Q54115668-EA8D3C9C-B4FD-4836-B326-E625972DA5EC

P698

Q54115668-0280CCCB-8364-4368-BBF1-996AFFE0D47E

P921

Q54115668-95DF9D41-F773-47A3-A058-C0466DBA7538

Q54115668-E144F937-85EE-40A8-9B23-07538492E700

P356

01.CIR.98.21.2262

P1433

P1476

Short-term oral endothelin-rec ...... severe chronic heart failure.

@en

P2093

G Sütsch

http://www.w3.org/2001/XMLSchema#string

J H Kim

http://www.w3.org/2001/XMLSchema#string

O Bertel

http://www.w3.org/2001/XMLSchema#string

P Hunziker

http://www.w3.org/2001/XMLSchema#string

P Rickenbacher

http://www.w3.org/2001/XMLSchema#string

S Christen

http://www.w3.org/2001/XMLSchema#string

W Kiowski

http://www.w3.org/2001/XMLSchema#string

W Strobel

http://www.w3.org/2001/XMLSchema#string

X W Yan

http://www.w3.org/2001/XMLSchema#string

P304

2262-2268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.98.21.2262

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9826312

http://www.w3.org/2001/XMLSchema#string

P921